Seer, Inc. is facing increasing pressure from its shareholders following a recent filing by BML Investment Partners, L.P. The investment firm has expressed disappointment over the board's decision to reject acquisition proposals, urging the board to reconsider its stance. This situation is significant as it underscores the ongoing challenges within the laboratory analytical instruments sector, where companies are expected to create shareholder value.

In a letter to the board dated November 2, 2026, BML Investment Partners outlined their dissatisfaction with the board's recent decisions, specifically regarding the rejection of acquisition offers that valued the company at between $2.45 and $2.55 per share. BML holds a substantial stake in Seer, owning 2,180,490 shares, which represents approximately 3.9% of the company's total shares outstanding. Additionally, Braden M. Leonard, the managing member of BML Capital Management, LLC, owns another 420,000 shares, bringing the total to 2,600,490 shares or 4.7% of the total shares.

Background

Seer, Inc., incorporated in Delaware, operates in the laboratory analytical instruments sector (SIC 3826). The company is publicly traded on the Nasdaq under the ticker SEER. Recent filings indicate that Seer has been navigating a challenging financial landscape, which has raised concerns among investors about its future performance.

What the Filing Says

The filing reveals that BML Investment Partners is dissatisfied with the board's decision to remain a public company and has urged the board to adhere to its fiduciary responsibilities. The letter states, "BML is very disappointed with the Board’s decision last week to reject both acquisition proposals that were presented earlier this year." This sentiment is echoed by the market, as the stock price declined by 13% to $1.69 per share following the board's announcement.

Impact

This development could significantly impact Seer's future strategies and operations, particularly as BML Investment Partners holds a notable percentage of shares. The pressure from a substantial shareholder like BML may force the board to reconsider its approach to maximizing shareholder value. Additionally, the situation could influence how other companies in the laboratory analytical instruments sector respond to similar pressures from their investors.

What's Next

The filing does not specify what will happen next. However, the ongoing dialogue between BML Investment Partners and Seer’s board may lead to further developments in the coming weeks as both parties navigate this challenging situation.